Nick Muscato - 16 Feb 2024 Form 4 Insider Report for AMEDISYS INC (AMED)

Role
Chief Strategy Officer
Signature
Jennifer Guckert Griffin, pursuant to a power of attorney
Issuer symbol
AMED
Transactions as of
16 Feb 2024
Net transactions value
-$30,637
Form type
4
Filing time
21 Feb 2024, 21:03:38 UTC
Previous filing
27 Jul 2023
Next filing
29 Jul 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AMED Common Stock Award $0 +5,518 +36% $0.000000 20,843 16 Feb 2024 Direct F1
transaction AMED Common Stock Tax liability $30,637 -327 -1.6% $93.69 20,516 20 Feb 2024 Direct
holding AMED Common Stock 212 16 Feb 2024 By 401(k) Plan F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Issuer awarded the Reporting Person 5,518 time-based RSUs, each of which represents a contingent right to receive one share of the Issuer's common stock, and will vest in equal, 1/4 installments on each of February 16, 2025, 2026, 2027 and 2028, provided that the Reporting Person remains continuously employed by the Issuer on each such date.
F2 The information in this report is based on a plan statement dated as of December 31, 2023.